** watch future Linda Hall Library lectures live at new.livestream.com/lindahall ** May 10, 2018, in the Main Reading Room of the Linda Hall Library. The lecture: New gene editing technologies like CRISPR have enabled exciting advances in science and health and led to a wealth of related emerging biotechnologies, from gene drives to the next generation of chimeric animal models. But some applications of CRISPR are raising ethical and other concerns, and are presenting interesting policy challenges to our current oversight system for research in the life sciences. What can we learn from previous experiences with emerging biotechnologies and how can we adapt our current policy framework to the gene editing technologies of today and tomorrow? The speaker: Dr. Carrie Wolinetz is Associate Director for Science Policy and Director of the Office of Science Policy (OSP) at the National Institutes of Health (NIH). As leader of OSP, she advises the NIH Director on science policy matters of significance to the agency, the research community, and the public, on a wide range of issues including human subjects protections, biosecurity, biosafety, genomic data sharing, regenerative medicine, the organization and management of NIH, and the outputs and values of NIH-funded research. She has a BS in animal science from Cornell University and a PhD in animal science from The Pennsylvania State University, where her area of research was reproductive physiology. Video produced by The VideoWorks of Roeland Park, Kansas.

Be the first to comment